Tag: Dr Vasan Sambandamurthy
“Our lead antibacterial asset is undergoing first-in-human phase-I clinical trials”
Dr Vasan Sambandamurthy, Senior Vice President, Bugworks Research India shares his views on the current biotech and startup scenario, his company’s journey so far, R&D initiatives and future outlook
BioVoice eMagazine February 2023 Issue 2 Volume 4
Click to Read: February 2023 Edition of BioVoice eMagazine
The Cover Story in the February 2023 issue focuses on the ambitious US$ 300 billion bioeconomy...
Dr Vasan Sambandamurthy to be the new CEO of DBT/Wellcome Trust...
Indian science funding charity, DBT/Wellcome Trust India Alliance (India Alliance) has announced the appointment of Dr Vasan Sambandamurthy as its next CEO. He will succeed Dr. Shahid Jameel on 1 October 2020..................